Precision Health Clinical Trials
HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma, Scirrhous; Recurrence Tumor
Intervention: Procedure: liver transplant
Sponsors: Centro Hospitalar de Lisboa Central; Ophiomics - Precision Medicine
Recruiting
Intervention: Procedure: liver transplant
Sponsors: Centro Hospitalar de Lisboa Central; Ophiomics - Precision Medicine
Recruiting
For more information, visit the Study URL.
Genomics and Metagenomics of Asthma Severity
Conditions: Asthma; Asthma Attack
Intervention:
Sponsors: Maria Pino-Yanes; University of La Laguna; Spanish Ministry of Science, Innovation, and Universities; Consorcio Centro de Investigación Biomédica en Red (CIBER); University Hospital of the Nuestra Señora de Candelaria; Hospital Universitario de Canarias; Hospital General de La Palma; Hospital Universitario Donostia; Hospital Doctor Jose Molina Orosa
Recruiting
Intervention:
Sponsors: Maria Pino-Yanes; University of La Laguna; Spanish Ministry of Science, Innovation, and Universities; Consorcio Centro de Investigación Biomédica en Red (CIBER); University Hospital of the Nuestra Señora de Candelaria; Hospital Universitario de Canarias; Hospital General de La Palma; Hospital Universitario Donostia; Hospital Doctor Jose Molina Orosa
Recruiting
For more information, visit the Study URL.
Predictors of Better Outcomes After Severe Acquired Brain Injuries
Conditions: Brain Injuries; Disorder of Consciousness
Intervention: Genetic: Genetic analysis of different single nucleotide polymorphisms on ApoE, BDNF and DRD2 genes assessment
Sponsor: Fondazione Don Carlo Gnocchi Onlus
Recruiting
Intervention: Genetic: Genetic analysis of different single nucleotide polymorphisms on ApoE, BDNF and DRD2 genes assessment
Sponsor: Fondazione Don Carlo Gnocchi Onlus
Recruiting
For more information, visit the Study URL.
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Condition: Parkinson Disease
Intervention:
Sponsors: Michael J. Fox Foundation for Parkinson's Research; Institute for Neurodegenerative Disorders
Recruiting
Intervention:
Sponsors: Michael J. Fox Foundation for Parkinson's Research; Institute for Neurodegenerative Disorders
Recruiting
For more information, visit the Study URL.
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)
Conditions: Hepatocellular Cancer; Cholangiocarcinoma; Gallbladder Cancer; Pancreatic Cancer; Oesophageal Cancer; Stomach Cancer
Intervention: Diagnostic Test: FoundationOne®CDx and FoundationOne®Liquid
Sponsors: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Roche Pharma AG
Recruiting
Intervention: Diagnostic Test: FoundationOne®CDx and FoundationOne®Liquid
Sponsors: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Roche Pharma AG
Recruiting
For more information, visit the Study URL.
Detection of Genetic Markers of Lung Cancer
Condition: Lung Cancer
Interventions: Procedure: Biopsy of the major carinal area; Procedure: Biopsy of abnormal & suspicious areas of the bronchial tree; Procedure: Evaluation of the tumor for DNA mutations; Procedure: Bronchoalveolar Lavage (BAL) for cytokine analysis; Procedure: Correlation of flow cytometric & RT PCR for TNM stage; Procedure: Analysis of lymph nodes
Sponsors: University of Pittsburgh; National Institutes of Health (NIH)
Recruiting
Interventions: Procedure: Biopsy of the major carinal area; Procedure: Biopsy of abnormal & suspicious areas of the bronchial tree; Procedure: Evaluation of the tumor for DNA mutations; Procedure: Bronchoalveolar Lavage (BAL) for cytokine analysis; Procedure: Correlation of flow cytometric & RT PCR for TNM stage; Procedure: Analysis of lymph nodes
Sponsors: University of Pittsburgh; National Institutes of Health (NIH)
Recruiting
For more information, visit the Study URL.
Longitudinal Follow-up Study in Two Chinese Hypertension Cohorts
Condition: Hypertension
Intervention: Other: Incidence and risk factors of hypertension
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Not yet recruiting
Intervention: Other: Incidence and risk factors of hypertension
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Not yet recruiting
For more information, visit the Study URL.
A Phase 1 Trial of the p97 Inhibitor CB-5339 in Patients With Advanced Solid Tumors and Lymphomas
Conditions: Advanced Solid Tumors; Advanced Lymphomas
Intervention: Drug: CB-5339
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
Intervention: Drug: CB-5339
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
For more information, visit the Study URL.
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Condition: Neoplasms
Interventions: Drug: Nilotinib; Drug: Paclitaxel
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
Interventions: Drug: Nilotinib; Drug: Paclitaxel
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
For more information, visit the Study URL.
Evaluation of Clinical, Radiomics and Molecular Features of Lung Metastasis in PDAC Patients (LUMACA Trial)
Condition: Pancreas Adenocarcinoma
Interventions: Genetic: Analysis of genetic mutations and the gene expression profile of lung metastasis and primary neoplasia; Other: Radiomics analysis on TAC imaging at diagnosis of lung metastasis and, if possible, of the primary tumor
Sponsor: IRCCS San Raffaele
Recruiting
Interventions: Genetic: Analysis of genetic mutations and the gene expression profile of lung metastasis and primary neoplasia; Other: Radiomics analysis on TAC imaging at diagnosis of lung metastasis and, if possible, of the primary tumor
Sponsor: IRCCS San Raffaele
Recruiting
For more information, visit the Study URL.